Allergan Plc will stop selling some breast implants after the U.S. Food and Drug Administration said that textured implants had been associated with a rare type of blood cancer.
Allergan’s textured Biocell saline-filled and silicone-filled breast implants and tissue expanders will no longer be distributed or available around the world, Allergan said in a statement July 24. The company asked health-care providers to not use new Biocell implants and to return unused products.
The FDA hasn’t recommended removal or replacement of the implants in patients with no symptoms, Allergan said.
Textured implants have been associated with rare cases of anaplastic ...